Bayer pays $310M to buy into BridgeBio heart drug

cafead

Administrator
Staff member
  • cafead   Mar 04, 2024 at 12:22: PM
via The deal gives the German pharma partial rights to acoramidis, a treatment that could soon become a marketed rival of a fast-selling Pfizer medicine.

article source